Testing effectiveness (Phase 2)UnknownNCT01158105
What this trial is testing
Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
Who this might be right for
Chronic Graft-versus-host Disease
Baylor Research Institute 25
Showing 20 of 0 results